Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease

Autor: Wibke Reinhard, Klaus Stark, Christian Hengstenberg, Jeanette Erdmann, Heribert Schunkert, Thomas Illig, Martina Grassl
Rok vydání: 2009
Předmět:
Male
Gout
Glucose Transport Proteins
Facilitative

Cardiovascular Disorders/Coronary Artery Disease
lcsh:Medicine
Genome-wide association study
Coronary Artery Disease
Gastroenterology
chemistry.chemical_compound
0302 clinical medicine
ATP Binding Cassette Transporter
Subfamily G
Member 2

030212 general & internal medicine
lcsh:Science
Genetics and Genomics/Genetics of Disease
Aged
80 and over

0303 health sciences
Multidisciplinary
biology
Middle Aged
Neoplasm Proteins
3. Good health
Female
SLC22A12
Cardiovascular Disorders/Myocardial Infarction
Research Article
Adult
medicine.medical_specialty
Single-nucleotide polymorphism
Genetics and Genomics/Complex Traits
Polymorphism
Single Nucleotide

03 medical and health sciences
Internal medicine
Genetics and Genomics/Population Genetics
medicine
Humans
Genetic Predisposition to Disease
Risk factor
Aged
030304 developmental biology
Polymorphism
Genetic

lcsh:R
Case-control study
medicine.disease
Uric Acid
Endocrinology
chemistry
Case-Control Studies
biology.protein
Uric acid
ATP-Binding Cassette Transporters
lcsh:Q
Genome-Wide Association Study
SLC2A9
Zdroj: PLoS ONE, Vol 4, Iss 11, p e7729 (2009)
PLoS ONE 4:e7729 (2009)
PLoS ONE
ISSN: 1932-6203
Popis: Background Recently, a large meta-analysis including over 28,000 participants identified nine different loci with association to serum uric acid (UA) levels. Since elevated serum UA levels potentially cause gout and are a possible risk factor for coronary artery disease (CAD) and myocardial infarction (MI), we performed two large case-control association analyses with participants from the German MI Family Study. In the first study, we assessed the association of the qualitative trait gout and ten single nucleotide polymorphisms (SNP) markers that showed association to UA serum levels. In the second study, the same genetic polymorphisms were analyzed for association with CAD. Methods and Findings A total of 683 patients suffering from gout and 1,563 healthy controls from the German MI Family Study were genotyped. Nine SNPs were identified from a recently performed genome-wide meta-analysis on serum UA levels (rs12129861, rs780094, rs734553, rs2231142, rs742132, rs1183201, rs12356193, rs17300741 and rs505802). Additionally, the marker rs6855911 was included which has been associated with gout in our cohort in a previous study. SNPs rs734553 and rs6855911, located in SLC2A9, and SNP rs2231142, known to be a missense polymorphism in ABCG2, were associated with gout (p = 5.6*10−7, p = 1.1*10−7, and p = 1.3*10−3, respectively). Other SNPs in the genes PDZK1, GCKR, LRRC16A, SLC17A1-SLC17A3, SLC16A9, SLC22A11 and SLC22A12 failed the significance level. None of the ten markers were associated with risk to CAD in our study sample of 1,473 CAD cases and 1,241 CAD-free controls. Conclusion SNP markers in SLC2A9 and ABCG2 genes were found to be strongly associated with the phenotype gout. However, not all SNP markers influencing serum UA levels were also directly associated with the clinical manifestation of gout in our study sample. In addition, none of these SNPs showed association with the risk to CAD in the German MI Family Study.
Databáze: OpenAIRE